Cargando…

Assessing Pharmacodynamic Effects of Antiplatelet Agents With Different Mechanisms of Action

Detalles Bibliográficos
Autores principales:	Schneider, David J., Taatjes‐Sommer, Heidi S., Prats, Jayne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200719/ https://www.ncbi.nlm.nih.gov/pubmed/33880929 http://dx.doi.org/10.1161/JAHA.120.020859

Ejemplares similares

Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study
por: Franchi, Francesco, et al.
Publicado: (2022)

Antiplatelet Agents in Sepsis—Putting it all together: A Call to Action
por: Tiwari, Nishant R, et al.
Publicado: (2020)

Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents
por: Wiederhold, Nathan P.
Publicado: (2022)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

New anticoagulants and antiplatelet agents in perioperative period: Recommendations and controversies!
por: Nair, Abhijit S, et al.
Publicado: (2017)

Effect of antiplatelet agents on Escherichia coli sepsis mechanisms: A review
por: Mariotti, Antoine, et al.
Publicado: (2022)

Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation
por: Angiolillo, Dominick J., et al.
Publicado: (2022)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients
por: Grzybowski, Andrzej, et al.
Publicado: (2018)

The Antiplatelet Effect of 4-Methylcatechol in a Real Population Sample and Determination of the Mechanism of Action
por: Hrubša, Marcel, et al.
Publicado: (2022)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Patterns of antiplatelet agent use in the US
por: Kanakadandi, Vijay, et al.
Publicado: (2015)

Comparative Effectiveness Review of Antiplatelet Agents in Peripheral Artery Disease
por: Schmit, Kristine, et al.
Publicado: (2014)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

EFFECT OF ANTICOAGULATION AND ANTIPLATELET AGENTS ON HYPERCOAGULABILITY STATES IN PATIENTS WITH COVID-19
por: UR, JEANNIE, et al.
Publicado: (2021)

Clinically relevant exaggerated pharmacodynamic response to dual antiplatelet therapy detected by Thromboelastogram(®) Platelet Mapping™
por: Hiller, Kenneth N.
Publicado: (2016)

Proton Pump Inhibitors in Pediatrics: Mechanism of Action, Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics
por: Ward, Robert M., et al.
Publicado: (2013)

Newer agents in antiplatelet therapy: a review
por: Yeung, Jennifer, et al.
Publicado: (2012)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Vorapaxar: The missing link in antiplatelet therapy!
por: Nair, Abhijit S.
Publicado: (2017)

Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study
por: Angiolillo, Dominick J., et al.
Publicado: (2019)

Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents
por: Xu, Junchao, et al.
Publicado: (2023)

Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents
por: Oh, Hyoung-Chul, et al.
Publicado: (2018)

Effects of Antiplatelet Agents on Bleeding after Endoscopic Resection of Gastric Tumor
por: Ahn, Ji Yong
Publicado: (2018)

Effects of Preoperative Antiplatelet Agents and Anticoagulants on Total Joint Arthroplasty Outcomes
por: Sumarriva, Gonzalo, et al.
Publicado: (2021)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Pharmacodynamics and Pharmacokinetics of oral factor Xa inhibitors
por: Persson, Pontus B
Publicado: (2015)

Stopping “transient ischemic attacks” by antiplatelet withdrawal
por: Palaiodimou, Lina, et al.
Publicado: (2021)

Emerging antiplatelet agents, differential pharmacology, and clinical utility
por: Das, Pranab, et al.
Publicado: (2010)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Ticagrelor: The first approved reversible oral antiplatelet agent
por: Goel, Divya
Publicado: (2013)

Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly
por: De Bonis, Pasquale, et al.
Publicado: (2013)

Role of sodium tungstate as a potential antiplatelet agent
por: Fernández-Ruiz, Rebeca, et al.
Publicado: (2015)

Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents
por: Zullo, Angelo, et al.
Publicado: (2017)

Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016)

Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?
por: Borges, Juliana Maria Dantas Mendonça, et al.
Publicado: (2018)

Preparations from selected cucurbit vegetables as antiplatelet agents
por: Rolnik, Agata, et al.
Publicado: (2021)

Assessing the relative efficacy of different agents based on the outcomes from meta-analyses
por: Boonen, S, et al.
Publicado: (2008)

Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i4q3jm08hol4ca9bdc78p37tm6